E-LIB Suche - Ergebnisse für: LI, Chenggong

1

Exploration of a New Smart Pension Model in Anhui Province ..:

Ji, Haowen ; Li, Chenggong ; Wang, Zhiqing.
International Journal of Global Economics and Management. 3 (2024) 2 - p. 170-184 , 2024

Link: https://doi.org/10.62051..

2

Targeting autophagy overcomes cancer‐intrinsic resistance t..:

Tang, Lu ; Zhang, Huan ; Zhou, Fen...
Cancer Communications. 44 (2024) 3 - p. 408-432 , 2024

Link: https://doi.org/10.1002/..

3

Treatment of multiple myeloma: What is the impact on T-cell..:

Li, Chenggong ; Wang, Xindi ; Xu, Jia..
Therapeutic Advances in Hematology. 15 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

4

Off-the-shelf CAR-T cell therapies for relapsed or refracto..:

Kang, Yun ; Li, Chenggong ; Mei, Heng
Journal of Hematology & Oncology. 17 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

5

Targeting CD22 for B-cell hematologic malignancies:

Xu, Jia ; Luo, Wenjing ; Li, Chenggong.
Experimental Hematology & Oncology. 12 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

6

IL-10 plus the EASIX score predict bleeding events after an..:

Wang, Xindi ; Li, Chenggong ; Luo, Wenjing...
Annals of Hematology. 102 (2023) 12 - p. 3575-3585 , 2023

Link: https://doi.org/10.1007/..

7

Bispecific CS1-BCMA CAR-T cells are clinically active in re..:

Li, Chenggong ; Xu, Jia ; Luo, Wenjing...
Leukemia. 38 (2023) 1 - p. 149-159 , 2023

Link: https://doi.org/10.1038/..

8

P1393: BISPECIFIC CD19/CD37 CAR-T CELLS IN PATIENTS WITH RE..:

Luo, Wenjing ; LI, Chenggong ; Zhang, Yinqiang...
HemaSphere. 7 (2023) S3 - p. e4325339 , 2023

Link: https://doi.org/10.1097/..

9

Plasma proteomic and metabolomic signatures of B‐ALL patien..:

Wu, Jianghua ; Tang, Lu ; Du, Mengyi...
Clinical and Translational Medicine. 13 (2023) 3 - p. , 2023

Link: https://doi.org/10.1002/..

10

P1404: IL-10 PLUS THE EASIX SCORE PREDICT BLEEDING EVENTS A..:

Wang, Xindi ; LI, Chenggong ; Luo, Wenjing...
HemaSphere. 7 (2023) S3 - p. e46287f9 , 2023

Link: https://doi.org/10.1097/..

11

Novel CD19-specific γ/δ TCR-T cells in relapsed or refracto..:

Li, Chenggong ; Zhou, Fen ; Wang, Jing...
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

12

Bruton tyrosine kinase inhibitors preserve anti-CD19 chimer..:

Luo, Wenjing ; Li, Chenggong ; Wu, Jianghua...
Cytotherapy. 25 (2023) 7 - p. 739-749 , 2023

Link: https://doi.org/10.1016/..

13

Allogenic and autologous anti-CD7 CAR-T cell therapies in r..:

Zhang, Yinqiang ; Li, Chenggong ; Du, Mengyi...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

14

Timing of Tocilizumab Administration Under the Guidance of ..:

Zhang, Yinqiang ; Zhou, Fen ; Wu, Zhuolin...
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

15

Kanglaite upregulates CD4+ T cells by inhibiting the expres..:

Li, Chenggong ; Feng, Yigeng
STEMedicine. 3 (2022) 4 - p. e149 , 2022

Link: https://doi.org/10.37175..